180 Life Sciences Corp. (ATNF): Price and Financial Metrics
ATNF Price/Volume Stats
| Current price | $1.07 | 52-week high | $17.75 |
| Prev. close | $1.11 | 52-week low | $0.98 |
| Day low | $1.03 | Volume | 18,403 |
| Day high | $1.12 | Avg. volume | 128,680 |
| 50-day MA | $1.30 | Dividend yield | N/A |
| 200-day MA | $1.97 | Market Cap | 3.40M |
ATNF Stock Price Chart Interactive Chart >
180 Life Sciences Corp. (ATNF) Company Bio
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and Anti-TNF platform, which focuses on fibrosis and anti-tumor necrosis factors; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Menlo Park, California.
ATNF Price Returns
| 1-mo | -14.40% |
| 3-mo | N/A |
| 6-mo | -38.86% |
| 1-year | -49.29% |
| 3-year | -99.90% |
| 5-year | N/A |
| YTD | -41.21% |
| 2024 | -55.13% |
| 2023 | -93.70% |
| 2022 | -95.65% |
| 2021 | 42.86% |
| 2020 | N/A |
Loading social stream, please wait...